Research Article

Urinary Polycyclic Aromatic Hydrocarbon Metabolites and Attention/Deficit Hyperactivity Disorder, Learning Disability, and Special Education in U.S. Children Aged 6 to 15

Table 1

Urinary PAH metabolite concentrations (ng/L), NHANES 2001–2004 participants aged 6–15 with no missing covariates or outcomes ( ).

PAH
metabolite
Percent below LODaMinimumPercentiles (95% confidence intervals)Maximum
5th10th25th50th75th95th

1-pyrene0.52.115.3
(11.6, 18.9)
21.7
(18.6, 24.8)
37.9
(32.9, 42.9)
76.1
(65.0, 87.2)
161.0
(143.4, 178.6)
483.5
(61.6, 357.8)
2216
1-napthol0.133263.8
(93.5, 334.1)
404.1
(334.7, 473.5)
722.5
(648.2, 796.7)
1290.1
(1140.9, 1439.2)
2969.2
(2572.6, 3365.9)
11165
(9373.5, 12956.1)
567902
2-napthol027354.5
(269.8, 439.2)
619.3
(527.4, 711.1)
1063.9
(977.8, 1150.0)
2036.6
(1812.7, 2260.5)
3622.8
(3233.3, 4012.3)
9748.2
(7344.2, 12152.1)
345241
FLUO metabolites
 2-fluorene0452.1
(43.7, 60.4)
81.2
(66.7, 95.8)
141.8
(126.9, 156.8)
254.3
(228.0, 280.6)
395.9
(357.8, 434.0)
875.1
(772.8, 977.3)
7828.6
 3-fluorene0.13.522.3
(17.2, 27.5)
33.9
(28.1, 39.7)
60.9
(53.5, 68.3)
102.2
(94.7, 109.7)
167.0
(154.7, 179.2)
386.3
(322.8, 449.8)
3462.7
PHEN metabolites
 1-phenanthrene0.32.830.0
(24.3, 35.8)
43.0
(36.3, 49.6)
74.8
(66.2, 83.5)
128.7
(116.2, 141.2)
225.1
(201.4, 248.8)
506.5
(407.5, 605.6)
2297
 2-phenanthrene4.12.15.8
(2.0, 9.6)
12.4
(8.9, 16.0)
24.9
(20.5, 29.3)
49.1
(43.9, 54.4)
82.9
(74.2, 91.7)
226.6
(195.2, 257.9)
2469
 3-phenanthrene0.62.822.9
(18.3, 27.4)
35.1
(30.3, 40.0)
61.3
(55.6, 66.9)
106.0
(94.0, 118.0)
186.8
(167.7, 205.8)
413.6
(315.1, 512.1)
19643

Limits of detection (LOD) (ng/L) for PAH metabolites.
2001-2002: 1-pyrene: 3.3, 1-napthol: 6.2, 2-napthol: 2.4, 2-fluorene: 3.6, 3-fluorene: 2.0, 1-phenanthrene: 3.5, 2-phenanthrene: 3.2, and 3-phenanthrene: 3.6.
2003-2004: 1-pyrene: 4.9, 1-napthol: 18, 2-napthol: 12, 2-fluorene: 4.5, 3-fluorene: 6.9, 1-phenanthrene: 2.6, 2-phenanthrene: 3.8, and 3-phenanthrene: 2.6.